Gene Therapy for Spinal Muscular Atrophy (1 of 1) (IMAGE)

American Association for the Advancement of Science (AAAS)

Gene Therapy for Spinal Muscular Atrophy (1 of 1)

Caption

This image shows the expression of green fluorescent protein (GFP, green) in a rodent spinal cord after gene therapy treatment. The transduced cells express the GFP, indicating an efficient transduction of the central nervous system. This material relates to a paper that appeared in the March 13, 2015, issue of Science, published by AAAS. The paper, by M. Nizzardo at University of Milan in Milan, Italy, and colleagues was titled, 'Gene therapy rescues disease phenotype in a spinal muscular atrophy with respiratory distress type 1 (SMARD1) mouse model.'

Credit

[Credit: Monica Nizzardo PhD, University of Milan]

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.